Radiance Biopharma, Inc. — Form D

Radiance Biopharma, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2024-02-28. The offering totals $30.0M, of which $250K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2024-02-28
• Form: D
• Accession: 0002013052-24-000003
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $30.0M
• Amount sold: $250K
• Remaining: $29.8M
• Investors: 1
• Date of first sale: 2024-02-13
• Security types: debt
• Revenue range: Decline to Disclose
• SEC file number: 021-506309

Issuer

• Name: Radiance Biopharma, Inc.
• CIK: 0002013052
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2023
• Address: ONE BOSTON PLACE, BOSTON, MA, 02108
• Phone: 617-621-7143

Officers, directors & promoters (4)

More

• CIK 2013052 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search